A Case of Primary Intraocular Lymphoma Treated by Intravitreal Methotrexate
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A 40-year-old female visited our clinic for visual disturbance of the right eye, in which a few creamy-yellow retinal lesions and visual field constrictions were noted. She had been treated for primary CNS lymphoma and was in complete remission. After failure to follow-up for three months, she lost vision in the right eye, at which time active panuveitis was seen. Decreased vision and field constriction was observed in the left eye. Her left eye showed a granular pattern and dye leakage from the vessels and disc on fluorescein angiography and small RPE humps were seen in optical coherence tomography (OCT). Diffuse large malignant B-cells with strong immunoreactivities with CD20 immunostaining were seen in the epiretinal membrane biopsy specimen. Intravitreal injections of methotrexate (MTX) (800 ㎍/0.1 ㎖ in the right eye, 400 ㎍/0.05 ㎖ in the left eye) were performed twice weekly for one month, once weekly for the following month, once every two weeks for the next month, followed by nine monthly injections. Both eyes were free from malignant cells on vitreous biopsy six months later. There was no leakage seen by angiography, but the granular pattern persisted. Visual field constriction was slightly improved, and the small RPE humpsdetachments seen in OCT disappeared. EOG Arden ratio was decreased in both eyes, and b wave amplitude of scotopic ERG was decreased in the left eye. She was free from recurrence until six months later. No ocular complications except minimal opacity of the crystalline lenses were noted in both eyes.
Abstract
A 40-year-old female visited our clinic for visual disturbance of the right eye, in which a few creamy-yellow retinal lesions and visual field constrictions were noted. She had been treated for primary CNS lymphoma and was in complete remission. After failure to follow-up for three months, she lost vision in the right eye, at which time active panuveitis was seen. Decreased vision and field constriction was observed in the left eye. Her left eye showed a granular pattern and dye leakage from the vessels and disc on fluorescein angiography and small RPE humps were seen in optical coherence tomography (OCT). Diffuse large malignant B-cells with strong immunoreactivities with CD20 immunostaining were seen in the epiretinal membrane biopsy specimen. Intravitreal injections of methotrexate (MTX) (800 ㎍/0.1 ㎖ in the right eye, 400 ㎍/0.05 ㎖ in the left eye) were performed twice weekly for one month, once weekly for the following month, once every two weeks for the next month, followed by nine monthly injections. Both eyes were free from malignant cells on vitreous biopsy six months later. There was no leakage seen by angiography, but the granular pattern persisted. Visual field constriction was slightly improved, and the small RPE humpsdetachments seen in OCT disappeared. EOG Arden ratio was decreased in both eyes, and b wave amplitude of scotopic ERG was decreased in the left eye. She was free from recurrence until six months later. No ocular complications except minimal opacity of the crystalline lenses were noted in both eyes.
참고문헌 (19)
- Chan CC, "Intraocular lymphoma", Curr Opin Ophthalmol, 13, pp.411~418 (2002)
- Peterson K, "The clinical spectrum of ocular lymphoma", Cancer, 72, pp.843~849 (1993)
- Davis JL, "Diagnosis of intraocular lymphoma", Ocul Immunol Inflamm, 12, pp.7~16 (2004)
- Nussenblatt RB, "International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future", Ocul Immunol Inflamm, 14, pp.139~144 (2006)
- Hochberg FH, "Primary central nervous system lymphoma", J Neurosurg, 68, pp.835~853 (1988)
- 이세훈, "안구를 침범한 원발성 중추신경계 림프종 1예", 대한안과학회지, 46(3), pp.26~26 (2005), 대한안과학회
- Nelson DF, "Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315", Int J Radiat Oncol Biol Phys, 23, pp.9~17 (1992)
- Batchelor TT, "High-dose methotrexate for intraocular lymphoma", Clin Cancer Res, 9, pp.711~715 (2003)
- Berenbom A, "Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy", Eye, 21, pp.1198~1201 (2007)
- Margolis L, "The role of radiation therapy in the management of ocular reticulum cell sarcoma", Cancer, 45, pp.688~692 (1980)
- Sou R, "Treatment of primary intraocular lymphoma with intravitreal methotrexate", Jpn J Ophthalmol, 52, pp.167~174 (2008)
- Frenkel S, "Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience", Br J Ophthalmol, 92, pp.383~388 (2008)
- Behin A, "Primary brain tumours in adults", Lancet, 361, pp.323~331 (2003)
- Rothova A, "Uveitis masquerade syndromes", Ophthalmology, 108, pp.386~399 (2001)
- Ursea R, "Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement", Retina, 17, pp.118~123 (1997)
- Corriveau C, "Lymphoma simulating uveitis (masquerade syndrome)", Can J Ophthalmol, 21, pp.144~149 (1986)
- Whitcup SM, "Intraocular lymphoma. Clinical and histopathologic diagnosis", Ophthalmology, 100, pp.1399~1406 (1993)
- Wang JK, "An Asian patient with intraocular lymphoma treated by intravitreal methotrexate", Jpn J Ophthalmol, 50, pp.474~478 (2006)
- Velez G, "Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma", Arch Ophthalmol, 119, pp.1518~1524 (2001)